Skip to main content
Ovation Science Inc. logo

Ovation Science Inc. — Investor Relations & Filings

Ticker · OVAT ISIN · CA69016D1087 LEI · 549300A1P7L8HTTQXY56 CSE Professional, scientific and technical activities
Filings indexed 252 across all filing types
Latest filing 2024-11-27 Regulatory Filings
Country CA Canada
Listing CSE OVAT

About Ovation Science Inc.

https://ovationscience.com/

Ovation Science Inc. is a research and development company specializing in advanced topical and transdermal product formulations. The core technology is Invisicare®, a patented, high-performance drug delivery system engineered to enhance the penetration and efficacy of active ingredients, particularly cannabis and hemp-derived cannabinoids (CBD, THC, CBN, CBG). Ovation utilizes pharmaceutical protocols to develop these formulations. Its primary business model involves licensing the Invisicare® technology and proprietary formulations to international partners for manufacturing and market distribution. The company also distributes finished topical CBD products under proprietary brands, such as the Invibe® MD wellness line and ARLO CBD Beauty anti-aging line, all leveraging the unique delivery capabilities of Invisicare®.

Recent filings

Filing Released Lang Actions
Interim MD&A - English.pdf
Regulatory Filings
2024-11-27 English
Interim financial statements/report – English.pdf
Regulatory Filings
2024-11-27 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2024-08-28 English
Interim MD&A - English.pdf
Regulatory Filings
2024-08-28 English
Interim financial statements/report – English.pdf
Regulatory Filings
2024-08-28 English
Form of proxy - English.pdf
AGM Information Classification · 100% confidence The document is a Form of Proxy for the Annual General Meeting (AGM) of Ovation Science Inc. It includes instructions for shareholders on how to appoint a proxy to vote on their behalf at the AGM, details on voting methods, and voting recommendations for resolutions such as election of directors, appointment of auditor, and approval of stock option plan. It also mentions the date and location of the AGM. There are no financial statements or detailed financial data included, nor is this a report or announcement of financial results. The document is clearly related to the AGM process and proxy solicitation, which fits the category of AGM Information (AGM-R). The document length (6521 characters) and content confirm it is not a brief announcement or a report publication notice but the actual proxy form for the AGM.
2024-08-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.